We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Researchers Create Menagerie of Biocompatible Micromachines

By LabMedica International staff writers
Posted on 18 Feb 2019
A team of Swiss biotech engineers has demonstrated possible medical applications for biocompatible micromachines constructed from gold nanorods coated with a thermoresponsive polymer.

Investigators at École Polytechnique Fédérale de Lausanne (Switzerland) combined several advanced techniques including programmable colloidal self-assembly, light-harvesting with plasmonic nanotransducers, and in situ polymerization of compliant hydrogel mechanisms to build biologically inspired, soft microelectromechanical systems (MEMS) devices. More...
These optomechanical microactuators were synthesized using a template-assisted microfluidic approach in which gold nanorods coated with a thermoresponsive polymer functioned as nanoscale building blocks.

The investigators reported in the February 4, 2019, online edition of the journal Lab on a Chip that near-infrared (NIR) laser illumination provided effective control over actuation of the resulting microactuators. These micromachines exhibited mechanical properties and performance characteristics that were comparable to those of bioengineered muscular constructs.

The investigators demonstrated the versatility of this approach by manufacturing a diverse array of microdevices including lever arms, continuum microrobots, and dexterous microgrippers.

"We wanted to create a modular system powered by the contraction of distributed actuators and the deformation of compliant mechanisms," said senior author Dr. Selman Sakar, an assistant professor in the institute of mechanical engineering at École Polytechnique Fédérale de Lausanne.

Related Links:
École Polytechnique Fédérale de Lausanne


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
New
Automated Urinalysis Solution
UN-9000
New
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The findings point to the feasibility of a quick, noninvasive urine-based approach to support earlier decision-making in multiple psychiatric conditions (photo credit: Shutterstock)

Noninvasive Urine Test May Support Earlier Diagnosis of Psychiatric Disorders

Delays in diagnosing serious psychiatric conditions can leave patients without timely support and complicate treatment planning. For bipolar disorder, average time to diagnosis can exceed nine years, and... Read more

Molecular Diagnostics

view channel
Image: The schematic diagram links key MASLD, MASH, and MASLD-HCC molecular drivers to emerging multi‑omics biomarkers and therapeutic modalities, highlighting the current barriers in clinical translation and strategic solutions aimed at refined risk stratification and personalized medicine (Photo courtesy of ©Science China Press)

Emerging Biomarkers Advance Early Detection of MASLD and Liver Cancer Risk

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects about 30% of people worldwide and can advance to metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, cirrhosis, and... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.